Clinical trial
Decreasing Leptospirosis Emergence Through Prognosis and Treatment Optimization (DeLEPTO) Project 1: Preventive Strategies for Early and Late Complications of Leptospirosis
NCT07127718 is registered in ClinicalTrials.gov with National Kidney and Transplant Institute, Philippines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Decreasing Leptospirosis Emergence Through Prognosis and Treatment Optimization (DeLEPTO) Project 1: Preventive Strategies for Early and Late Complications of Leptospirosis
- Lead sponsor
- National Kidney and Transplant Institute, Philippines
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 12, 2024
- Completion date
- March 31, 2027
- Enrollment
- 678 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.